期刊文献+

亚甲蓝光化学法灭活血液中HBV的初步探讨

An experimental study on the effect of methylene blue photochemistry to inactivate hepatitis B virus in blood
下载PDF
导出
摘要 目的:研究亚甲蓝光化学法对HBV的灭活效果。方法:选择慢性乙型病毒性肝炎患者30例,抽取其静脉血并使用亚甲蓝光化学法灭活HBV,以500μmol/L亚甲蓝灭活病毒1.5h后评价灭活效果,并检测灭活前后红细胞功能。结果:患者血液中HBV DNA拷贝数由灭活前的(1.19×107±1.23×106)copies/ml减少至灭活后的(3.46×105±5.01×104)copies/ml(P<0.05);红细胞丙二醛由灭活前的(2.5±0.2)mmol/L增加至灭活后的(9.1±1.7)mmol/L(P<0.05),而2,3-二磷酸甘油酸、Na+K+-ATP酶、Ca2+-ATP酶、Mg2+-ATP酶、血浆游离血红蛋白等无明显变化。结论:亚甲蓝光化学法能降低血液中HBV载量,对红细胞功能无明显影响。 Objective: To investigate the effect of methylene blue photochemistry (MBP) to inactivate hepatitis B virus (HBV) in blood. Methods: Thirty patients with chronic hepatitis B were randomly enrolled into the study and blood samples were obtained. The blood was treated with methylene blue 80 μmol/L for 1.5 h, then inactivation effect of MBP to HBV in venous blood was observed, as well as the erythrocyte function before and after the inactivation treatment was performed. Results: After the inactivation treatment, HBV DNA copies decreased significantly while malondialdehyde increased markedly, with no significant changes in 2, 3-DPG, Na ^+ K^ + -ATPase, Ca^2+ -ATPase, Mg^2+ -ATPase and free hemoglobin. Conclusion: MBP can effectively inactivate HBV without affecting erythrocyte function.
出处 《新医学》 2010年第8期506-507,514,共3页 Journal of New Medicine
关键词 乙型肝炎病毒 血液 光化学法 亚甲蓝 Hepatitis B virus Blood Photochemistry Methylene blue
  • 相关文献

参考文献9

  • 1KLEIN H G. Pathogen inactivation technology: cleansing the blood supply [ J ]. J Intern Med, 2005, 257 (3) : 224-237.
  • 2聂咏梅,张晓敏,周豪杰,付涌水,江朝富,汪传喜,陶黎阳,张甜,曹开源,田小东.核黄素联合紫外线A照射对血浆中伪狂犬病毒的灭活效果[J].中国输血杂志,2007,20(5):361-364. 被引量:5
  • 3PRATSCHKE J, MITTLER J, NEUHAUS P. Expanding the liver donor pool through extended-criteria donation [J]. Chirurg, 2008, 79 (2): 130-134.
  • 4MAIR D C, HIRSCHLER N, EASTLUND T. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI) [ J]. Crit Care Med, 2006, 34 (5 Suppl) : S137-S143.
  • 5OSSELAER J C, DEBRY C, GOFFAUX M, et al. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen [ J ] . Transfusion, 2008, 48 ( 1 ) : 108-117.
  • 6HARGREAVES A, TAIWO F A, DUGGAN O, et al. Near-ultraviolet photolysis of beta-phenylpyruvie acid generates free radicals and results in DNA damage [ J ]. J Photochem Photobiol B, 2007, 89 (2-3) : 110-116.
  • 7HATZAKIS A, MAGIORKINIS E, HAIDA C. HBV virological assessment[J]. J Hepatol, 2006, 44 (1 Suppl) : S71-S76.
  • 8赵鹃,严达刚,庞载元.荧光定量PCR检测HBV-DNA与血清标志物的关系探讨[J].实用医技杂志,2007,14(19):2533-2535. 被引量:4
  • 9成军.从乙型肝炎病毒准种特点看抗病毒治疗的艰巨性[J].新医学,2004,35(11):705-707. 被引量:7

二级参考文献16

  • 1Cummings PD, Wallace EL, Schorr JB, et al. Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody negative[J]. N Engl J Med. 1998, 321:942--946
  • 2Kumar V, Loekerbie O, Keil SD, et al, Riboflavin and UV- light based pathogen reduction: extent and consequence of DNAdamage at the molecular level[J]. Photochem Photeblol, 2004,80(1):15--21.
  • 3Goodrich L, Ghielli M, Hansen E, et al. Riboflavin and UV light inactivate enveloped and non-envelop viruses in platelet concentrates under conditions which maintain cell quallty[J].Vox Sang, 2002,83(2):111
  • 4黄桢祥.医学病毒学基础与实验技术[M].北京:科学技术出版社,1990:130-138
  • 5Ruane PH, Edrich R, Gampp D, et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light[J]. Transfusion, 2004,44:877--885
  • 6Li J, de Korte D, Woolum MD, et al. Pathogen reduction of bully coat platelet concentrates using riboflavin and lifht: comparisons with pathogen-reduction technology-treated apheresis platelet products[J]. Vox Sang, 2004,87(1) :82--90.
  • 7Aubuchon JP, Herschel L, Roger J, et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction[J]. Transfusion, 2005,45(8) :1335-- 1341
  • 8Roback JD, Conlan M, Drew WJ, et al. Then role of photochemical treatment with Amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. Transfusion Med Rev, 2006, 20(1): 45--56
  • 9Busch MP, Kleinman SH, Nemo GJ, Current and emerging infectious risks of blood transfusions[J]. J Am Med Assoc, 2003,289(8):959--962
  • 10Goodrich L, Douglas I, Uriosete M. Riboflavin photoinactivation procedure inactivates significant levels of bacteria and produces a culture negative product [J]. Transfusion, 2002, 42 (95):165--175

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部